M&A Deal Summary |
|
|---|---|
| Date | 2016-02-08 |
| Target | FSC Pediatrics |
| Sector | Medical Products |
| Buyer(s) | Avadel Pharmaceuticals |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2015 |
| Sector | Life Science |
| Revenue | 169M USD (2024) |
Avadel Pharmaceuticals is a biopharmaceutical company principally engaged in the development of two unique polymer-based delivery technologies for medical applications. Micropump is a controlled release and taste-masking technology for the oral administration of small molecule drugs. Its Medusa technology is designed to deliver controlled-release formulations of therapeutic proteins. Avadel Pharmaceuticals was founded in 2015 and is based in Dublin, Ireland.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Medical Products M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 2 of 2 |
| State: North Carolina M&A | 1 of 1 |
| Country: United States M&A | 2 of 2 |
| Year: 2016 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-12-01 |
Flamel Technologies - Development & Manufacturing Facility
France Flamel Technologies - Development & Manufacturing Facility comprises manufacturing facility of pharmaceutical products. |
Sell | - |
